Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Colgate-Palmolive Company for the period ended September 30, 1997. The company operates in the Oral, Personal, and Household Care segments, as well as Hill's Pet Nutrition. The financial statements reflect a two-for-one stock split approved in March 1997 and distributed in May 1997; all share and per-share amounts have been restated accordingly.
Key Financial Metrics
| Metric | Q3 1997 | Q3 1996 | 9 Months 1997 | 9 Months 1996 |
|---|---|---|---|---|
| Net Sales ($ Millions) | $2,297.2 | $2,230.6 | $6,745.2 | $6,451.6 |
| Gross Profit ($ Millions) | $1,166.7 | $1,094.8 | $3,415.4 | $3,159.1 |
| Gross Margin (%) | 50.8% | 49.1% | 50.6% | 49.0% |
| Net Income ($ Millions) | $188.6 | $160.9 | $534.0 | $453.3 |
| Earnings Per Share (Primary) | $0.62 | $0.53 | $1.76 | $1.49 |
| Operating Cash Flow ($ Millions) | N/A | N/A | $760.7 | $580.7 |
| Total Debt ($ Millions) | $2,867.7 | N/A | N/A | N/A |
| Cash and Equivalents ($ Millions) | $227.4 | N/A | N/A | N/A |
Note: Total Debt for Q3 1997 is the sum of Notes/loans payable ($285.7), Current portion of long-term debt ($115.3), and Long-term debt ($2,466.7).
Material Changes vs. Prior Period
- Sales Growth: Q3 1997 sales increased 3% year-over-year, driven by a 7% unit volume gain partially offset by foreign currency declines. For the nine-month period, sales rose 5% on 7% volume growth.
- Profitability: Net income increased 17% in Q3 and 18% for the nine-month period. Gross margins expanded due to streamlined manufacturing, regional sourcing, and a profitable product mix.
- Regional Performance:
- Latin America: Sales grew 15% in Q3 (12% volume) and 14% for nine months (11% volume).
- Europe: Sales declined 7% in Q3 and 5% for nine months due to currency weakness, despite underlying volume growth of 6% and 5% respectively.
- Asia/Africa: Sales were flat in Q3 due to sharp currency declines in Southeast Asia offsetting 6% volume growth.
- North America: Sales grew 5% in Q3 and 6% for nine months, aided by new product introductions.
- Expenses: Selling, general, and administrative (SG&A) expenses as a percentage of sales increased to 36.2% in Q3 (from 35.8%) due to higher advertising spend.
- Debt Reduction: Net interest expense decreased due to lower debt levels. Principal payments on debt totaled $300.7 million in the first nine months of 1997.
Guidance, Outlook, and Risks
- Outlook: Management notes that interim results may not be representative of full-year results. No specific forward-looking numerical guidance is provided in this filing.
- Legal Proceedings: The company is implementing undertakings with Brazilian antitrust authorities (CADE) regarding the Kolynos oral care business. This includes substituting a new toothpaste brand for Kolynos in Brazil for four years and contract manufacturing for third parties.
- Accounting Changes: The company will adopt SFAS No. 128 ("Earnings per Share") effective December 31, 1997, replacing primary and fully diluted EPS with basic and diluted EPS. Management states this will not materially affect financial condition or results.
- Liquidity: Working capital decreased to $308.1 million at September 30, 1997, from $468.0 million at year-end 1996. Commercial paper outstanding was $263.5 million, classified as long-term debt due to refinancing intent.
Key Facts for Investor Verification
- Verify the impact of foreign currency fluctuations on reported sales, particularly in the Asia/Africa and Europe regions where volume growth was offset by currency declines.
- Confirm the status of the Kolynos business in Brazil and compliance with CADE undertakings, as this affects long-term market presence in that region.
- Monitor the trend in SG&A expenses as a percentage of sales, which has increased due to advertising investments.
- Review the company's debt reduction strategy, noting the significant principal payments made in the first nine months of 1997.
- Check the upcoming adoption of SFAS No. 128 for consistency in future earnings per share reporting.